Zobrazeno 1 - 10
of 1 804
pro vyhledávání: '"anti-HLA"'
Autor:
Ram Mohan Jaiswal, Aseem Kumar Tiwari, Ashina Singla, Ashish Jain, Rajaat Vohra, Munish Kakkar, Prashanth Suravajhala
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 4, Pp 455-461 (2024)
Background: COVID-19 convalescent plasma is one of the experimental therapies used widely in moderately sick COVID-19 patients. However, there are a few risks involved in plasma transfusion; notably, transfusion-related acute lung injury (TRALI) caus
Externí odkaz:
https://doaj.org/article/c8437237fd7f41c587b2d035a82887ac
Autor:
Marc-Antoine Béland, Isabelle Lapointe, Isabelle Côté, Julie Lesage, Isabelle Houde, Eric Wagner, Julie Riopel, Eva Latulippe, Olivier Désy, Sacha A. De Serres
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionDe novo donor-specific HLA antibody (dnDSA) are associated with poor outcomes. Whether this observation applies to both HLA class I and II dnDSA remains unclear.MethodsWe studied 1236 consecutive kidney recipients who had routine anti-HLA
Externí odkaz:
https://doaj.org/article/9e7c44bfc3d74e3889687a4d836f7fc4
Publikováno v:
Transplant International, Vol 37 (2024)
There have been significant advances in short-term outcomes in renal transplantation. However, longer-term graft survival has improved only minimally. After the first post-transplant year, it has been estimated that chronic allograft damage is respon
Externí odkaz:
https://doaj.org/article/c170dd07154b48b1a79583b04f4f11d9
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Outcomes of haploidentical hematopoietic stem cell transplantation (haplo-SCT) have improved over time. Graft failure and graft-versus-host disease (GVHD), which were important complications in major human leukocyte antigen (HLA)-disparity stem cell
Externí odkaz:
https://doaj.org/article/bd8518eacbb34ab190fea7107096a383
Autor:
Simona Sica, Elisabetta Metafuni, Filippo Frioni, Maria Assunta Limongiello, Eugenio Galli, Federica Sorà, Andrea Bacigalupo, Elvira Poggi, Mariano Antonio Feccia, Annarita Manfreda, Patrizia Chiusolo, Sabrina Giammarco
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionDonor-specific antibodies (DSAs) correspond to anti-HLA antibodies of the recipient that are specifically directed to a mismatched antigen of the donor. In the setting of solid organ transplantation DSAs are associated with rejection. The
Externí odkaz:
https://doaj.org/article/6e0c5f20bd0d4291a1a8c0ceea66515d
Autor:
Haeun Lee, Hanbi Lee, In O Sun, Jung Hwan Park, Jong-Won Park, Tae Hyun Ban, Jaeseok Yang, Myoung Soo Kim, Chul Woo Yang, Byung Ha Chung, Korean Organ Transplantation Registry Study Group
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/ae5d3778a5b741818765ae61f0358fbb
Autor:
Haeun Lee, Hanbi Lee, In O Sun, Jung Hwan Park, Jong-Won Park, Tae Hyun Ban, Jaeseok Yang, Myoung Soo Kim, Chul Woo Yang, Byung Ha Chung, Korean Organ Transplantation Registry Study Group
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundPre-transplant donor-specific anti-human leukocyte antigen antibody (HLA-DSA) is a recognized risk factor for acute antibody-mediated rejection (ABMR) and allograft failure. However, the clinical relevance of pre-transplant crossmatch (XM)-
Externí odkaz:
https://doaj.org/article/ffaba7cce8a94e5191b330255fa57094
Autor:
Douglas J. Norman, C. Kristian Enestvedt, Willscott E. Naugler, Rouella Erhan, Carley A. Shaut
Publikováno v:
Frontiers in Nephrology, Vol 4 (2024)
IntroductionLiver transplant recipients may have pre-formed anti-HLA antibodies directed to mismatched HLA of the liver donor (donor specific antibodies, DSA) or not directed to the liver donor (non-donor specific, non-DSA). We observed the fate of t
Externí odkaz:
https://doaj.org/article/36b723b18c8d444a99c900ce14dc5986
Publikováno v:
Zhongguo shuxue zazhi, Vol 37, Iss 2, Pp 165-173 (2024)
Objective To explore the risk factors for the production of anti-HLA antibodies in patients with hematological diseases before hematopoietic stemcell transplantation. Methods The results and clinical data of 1 008 patients with hematological diseases
Externí odkaz:
https://doaj.org/article/114b204d713548aeb7e5d2ef0f324d60
Autor:
Qinqin Pan, Xiao Ma, Yajie You, Yuejiao Yu, Su Fan, Xiaoyan Wang, Mengyuan Wang, Ming Gao, Guangming Gong, Kourong Miao, Jie Shen, Xiaoyu Zhou
Publikováno v:
Immunity & Ageing, Vol 21, Iss 1, Pp 1-11 (2024)
Abstract Background With the development of Hematopoietic Stem Cell Transplantation (HSCT) technology, increasing numbers of elderly patients were undergoing allogeneic HSCT and elderly patients with hematologic malignancies could benefit most from i
Externí odkaz:
https://doaj.org/article/cf03428e94f8445087c6aa0a6bc3dbe9